1. Home
  2. BGH vs BDSX Comparison

BGH vs BDSX Comparison

Compare BGH & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Global Short Duration High Yield Fund of Beneficial Interests

BGH

Barings Global Short Duration High Yield Fund of Beneficial Interests

N/A

Current Price

$12.64

Market Cap

259.9M

Sector

Finance

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$10.36

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGH
BDSX
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.9M
276.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
BGH
BDSX
Price
$12.64
$10.36
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $32.60
AVG Volume (30 Days)
122.6K
★ 227.2K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 10.06%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $88,499,000.00
Revenue This Year
N/A
$26.35
Revenue Next Year
N/A
$20.40
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 24.08
52 Week Low
$12.37
$5.26
52 Week High
$15.35
$31.97

Technical Indicators

Market Signals
Indicator
BGH
BDSX
Relative Strength Index (RSI) 42.06 24.77
Support Level $12.37 N/A
Resistance Level $12.86 $11.57
Average True Range (ATR) 0.16 2.25
MACD 0.04 -1.34
Stochastic Oscillator 51.43 14.95

Price Performance

Historical Comparison
BGH
BDSX

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation. The Fund seeks capital appreciation as a secondary investment objective when consistent with its primary investment objective. Under normal market conditions, the Fund will invest at least 80% of its Managed Assets in bonds, loans and other income-producing instruments that are, at the time of purchase, rated below investment grade.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: